ライフサイエンスコーパス: nanocapsule

1 CeO2, as well as the polymer coating alone (nanocapsule).

2 l disruption to the overall structure of the nanocapsule.

3 t step toward development of a biocompatible nanocapsule.

4 stronger interaction of drug molecules with nanocapsule.

5 s essential oil-containing poly(lactic acid) nanocapsules.

6 nterior of gallium-seamed pyrogallol[4]arene nanocapsules.

7 additional shell covalently connected to the nanocapsules.

8 terior as well as exterior properties of the nanocapsules.

9 lysis of dye-sensitized, lipid-vesicle based nanocapsules.

10 and specifically functionalized to generate nanocapsules.

11 eveloping stably aerosolized PFC-based miRNA nanocapsules.

12 es and ill-defined oligomers to well-defined nanocapsules.

13 sassemble in organic solvents to produce PDA nanocapsules.

14 r aqueous domains of the lipid core of these nanocapsules.

15 bular topology and prevents the formation of nanocapsules.

16 of discrete nickel-seamed pyrogallol[4]arene nanocapsules.

17 ht-induced release of DHEA from targeted DNA nanocapsules.

18 chondrocytes which were pretreated with the nanocapsules.

19 l does not affect the fluorescence of poly A nanocapsules.

20 elf-assembles to form hierarchically ordered nanocapsules.

21 dynamic adaptability of tetragonal prismatic nanocapsule 1(8+) in the selective separation of fullere

22 mechanisms into two different, well-defined nanocapsules: (1) pH-induced assembly yielded 28 nm viru

23 le this problem is chemical synthesis inside nanocapsules, although enzyme-like control of such chemi

24 s that both drugs have good interaction with nanocapsule and can be carried to the target site easily

25 th Sleeping Beauty transposase in hyaluronan nanocapsules and injected them intravenously into hemoph

26 In the absence of human serum, nanocapsules and lipofectamine silenced expression of CC

27 The use of nanocapsules and related materials for drug delivery, as

28 idate the interplay between chondrocytes and nanocapsules and their therapeutic effect, we pursued a

29 teraction between adenine moieties of Poly A nanocapsules and thymine/uracil does not affect the fluo

30 solution, we can entrap charged molecules in nanocapsules and trigger the release of encapsulated con

31 ocytes did not show any adverse effects upon nanocapsule application and coherent anti-Stokes Raman s

32 bumins and hyaluronic acid shelled olive oil nanocapsules are analysed to discern differences between

33 Bionic nanocapsules are designed by cross-linking polythymine a

34 The curcumin-conjugated nanocapsules are found to be spherical in size and their

35 Dye-loaded nanocapsules are immobilized in a polyvinyl alcohol (PVA

36 payload release from these plasmon resonant nanocapsules are independently controlled using a pulsed

37 Liquid lipid nanocapsules are oil droplets surrounded by a protective

38 ficiently functionalizing the core of hollow nanocapsules are scarce.

39 These nanocapsules are stabilized by PAMD-C, which is a choles

40 miRNA nanocapsules are synthesized with enhanced stability for

41 t to functional beverages, but protein-based nanocapsules are unstable around the isoelectric point o

42 rted using functionalized firefly-luciferase nanocapsules as the probe.

43 min and quercetin co-encapsulated in shellac nanocapsules at different mass ratios were investigated

44 The stability of nanocapsules at different temperatures and pHs were also

45 n gold nanorod (AuNR)-encapsulated graphitic nanocapsule (AuNR@G), a photothermal agent, through pi-p

46 ay) was used to produce beta-carotene loaded nanocapsules based on whey protein isolate (WPI).

47 Herein, a nanocapsule-based delivery system is reported that enabl

48 Once in the tumour the outside shell of nanocapsules became degraded by overexpressed MMP-2 prot

49 significant increase in the mean size of the nanocapsules, being the sizes higher for nanocapsules pr

50 The aim of this study was to produce bixin nanocapsules by the interfacial deposition of preformed

51 e showcase the versatility of such molecular nanocapsules by tracking water cluster vibrations throug

52 repare docetaxel-loaded hyaluronic acid (HA) nanocapsules by using a self-emulsification process with

53 As the biomimetic nanocapsule can be decorated with any or multiple NPs, C

54 Dipole moment values indicate that nanocapsule can effectively release CP drug on a target

55 These nanocapsules can be conjugated to different targeting li

56 These nanocapsules can be conjugated with curcumin.

57 During synthesis the nanocapsules can be loaded with hydrophobic small molecu

58 Our CRISPR-Cas9 nanocapsules can be simply fabricated by encapsulating t

59 Electrosprayed WPI-based nanocapsules can be used for the encapsulation of beta-c

60 We hypothesize that nanocapsules can continuously be formed only when the mi

61 ine receptors and choline transporters, such nanocapsules can effectively penetrate the BBB and deliv

62 n the nanometer-thin shells of hollow porous nanocapsules can regulate the transport of charged molec

63 es affected the binding of cationic chitosan nanocapsules (Chi-NCs).

64 Particle deposition and nanocapsule clearance kinetics were measured by single p

65 , we show a novel delivery platform based on nanocapsules consisting of a protein core and a thin per

66 Redox-responsive nanocapsules consisting of conductive polyaniline and po

67 ZP consists of an iron-complexed tannic acid nanocapsule containing a vitamin D core, coated with PMB

68 tudy has also demonstrated that CeO2 NPs and nanocapsules containing Nile red are able to traverse th

69 Nanocapsules containing these antioxidants were effectiv

70 bining Raman spectroscopy with the molecular nanocapsule cucurbituril is a powerful technique to sequ

71 is challenge, we present here a single siRNA nanocapsule delivery technology, which is achieved by en

72 of curcumin is improved dramatically in such nanocapsules demonstrating that nanotechnology could be

73 In conclusion, the multilayer polymer nanocapsules described here are efficient vehicles for t

74 Nanocapsules displayed controlled release when compared

75 MS-DE or PDMS-DC) were encapsulated into the nanocapsules during the miniemulsion process and their r

76 We report herein a nanocapsule enzyme therapeutic based on lactate oxidase,

77 tends the application of such bioluminescent nanocapsules, especially in deep tissue.

78 Our encapsulating nanocapsules evidenced promising glioblastoma tissue tar

79 Such nanocapsules exhibit enhanced physicochemical performanc

80 The nanocapsules exhibit negligible immune clearance, minima

81 Notably, the nanocapsule exhibited a long circulation half-life of ~4

82 The nanocapsules exhibited an adequate stability in plasma.

83 Treatment with nanocapsules extended median survival time (68 days vers

84 s studies on utilizing polymeric vesicles as nanocapsules, fabrication of tunable molecular pathways

85 We designed a unique nanocapsule for efficient single CRISPR-Cas9 capsuling,

86 and characterized self-assembling lipid-core nanocapsules for coencapsulation of two poorly soluble n

87 mes offers a promising functionality to tune nanocapsules for encapsulating and releasing fluorescent

88 hnology not only demonstrates the use of UOx nanocapsules for hyperuricemia management, but also prov

89 ghlight the potential of self-emulsifying HA nanocapsules for intracellular drug delivery.

90 ing hyaluronan- and asialoorosomucoid-coated nanocapsules, generated using dispersion atomization, to

91 Interestingly, nanocapsules (>/= 800 mg/L) cause inhibition of hatch, a

92 The resulting nanocapsules had antimicrobial activity against E. coli,

93 The nanocapsules had discrete structures smaller than 50 nm

94 Manuka oil-nanoemulsions and nanocapsules had smaller particle sizes (343 and 330 nm)

95 The microfluidically-synthesized nanocapsules had well-controlled sizes of 100-200 nm, hi

96 the mechanism involved in the photolysis of nanocapsules has been opaque.

97 ork of nickel-seamed hexameric metal-organic nanocapsules has been synthesized by connecting the tail

98 The nanocapsules have a well-defined hole in the wall to ens

99 Polymer nanocapsules have demonstrated significant value in mate

100 Hybrid lipid nanocapsules (hLNCs) represent a promising platform for

101 he first-time encapsulation of Hy into lipid nanocapsules (Hy-LNCs), and then application of an Admin

102 e report self-assembled intertwining DNA-RNA nanocapsules (iDR-NCs) that efficiently delivered synerg

103 in we describe a nucleic acid functionalized nanocapsule in which nucleic acid ligands are assembled

104 reassembly could enable application of these nanocapsules in drug delivery and in nanomaterials synth

105 metal (Zn, Rb, or K) affords new trimetallic nanocapsules in solid state.

106 The monodisperse nanocapsules in the range of 50-200 nm consist of a dend

107 ligand pairing system, herein three types of nanocapsules, including a dimeric capsule, a Sierpinski

108 Rationally designed non-covalent protein nanocapsules incorporating copper-free "click chemistry"

109 ntalization of the indicator dyes within the nanocapsules increased their stability.

110 onally, the encapsulation of CCL2 within the nanocapsules induced a potent monocyte-macrophage chemoa

111 ternal cavity and sufficient dynamicity, the nanocapsule is able to recognize and encapsulate large a

112 A hexameric metal-organic nanocapsule is assembled from pyrogallol[4]arene units,

113 de new functionality to the microcapsule and nanocapsule is layer-by-layer deposition of functional s

114 The nanocapsule is remarkably robust, being stable at low an

115 work shows that surface functionalization of nanocapsules is an effective and innovative method of co

116 luidic platform for the synthesis of complex nanocapsules is presented via a controlled self-assembly

117 In the presence of serum, CCR5-siRNA nanocapsules knocked down CCR5-mCherry expression to les

118 (AuNPs) are used as a model to decorate the nanocapsule, light irradiation transiently increases the

119 ed and/or expanded, that possess extra-large nanocapsule-like cages, high porosity, and potential for

120 ere, we present curcumin-loaded liquid lipid nanocapsules (LLNs), obtained through olive oil emulsifi

121 these challenges, we developed a novel lipid nanocapsule (LNC) and chitosan/iota-carrageenan hydrogel

122 Lipid nanocapsules (LNCs) are semi-rigid spherical capsules wi

123 The porous nanocapsule loaded films showed excellent stability and

124 combining a cell-targetable, icosahedral DNA-nanocapsule loaded with photoresponsive polymers, we sho

125 y (butylene adipate-co-terephthalate) (PBAT) nanocapsules loaded with linalool EO were prepared using

126 In this work, we utilized polymeric magnetic nanocapsules (m-NCs) for magnetic targeting in tumors an

127 mary oils (RO) -containing nanoemulsions and nanocapsules made of sodium alginate and whey protein, w

128 Such nanocapsules maintain the integrity of siRNA inside even

129 -of-concept encapsulation of HRP through PSS nanocapsules may pave the way for alternative signal enh

130 report the use of stable magnetic graphitic nanocapsules (MGNs), for in situ targeted magnetic reson

131 nostics can be developed on the basis of the nanocapsule model described here.

132 crystallization propensity of metal-organic nanocapsules (MONCs).

133 However, drug stability inside the nanocapsule must be ensured to prevent burst release.

134 d for hyperuricemia treatment, as-formed UOx nanocapsules, n(UOx), exhibits enhanced stability, more

135 lently crosslinked polymer coating, called a nanocapsule (NC), around a preassembled ribonucleoprotei

136 Poly (D,L-lactide-coglycolide) nanocapsules (NC) were used to encapsulate 15d-PGJ(2).

137 act (MEPE) and their nanoencapsulation using nanocapsules (NC), liposomes (LP), and nanogels (NG).

138 Cl) embedded with an acid-responsive DNase I nanocapsule (NCa) was developed for targeted cancer trea

139 ramolecular engineering of water-dispersible nanocapsules (NCPs).

140 ssibility, we encapsulated HAs in lipid-core nanocapsules (NCs) based on a biodegradable and biocompa

141 This study investigated preparation of nanocapsules (NCs) containing food-grade ingredients usi

142 An original oral formulation of docetaxel nanocapsules (NCs) embedded in microparticles elicited i

143 Tacrolimus-loaded nanocapsules (NCs) were designed for ocular instillation

144 ynthesis of N-doped hollow mesoporous carbon nanocapsules (NHCNCs) with four different geometries has

145 The use of nanoparticle-stabilized nanocapsules (NPSCs) for the direct cytosolic delivery o

146 The self-assembly of the nanocapsule occurs such that the single resorcinol moiet

147 owever, it remains challenging to synthesize nanocapsules of a wide variety of hydrophobic drugs and

148 d to continuously produce TA-Fe(III) network nanocapsules of hydrophobic drugs.

149 For 120-170 nm spherical LbL nanocapsules of low soluble anticancer drugs, polyelectr

150 Light-addressable nanocapsules offer a powerful method for delivering spat

151 The self-assembly of porous molecular nanocapsules offer unique opportunities to investigate a

152 d the photothermal effects of ICG containing nanocapsules on EGFR-rich tumor cells.

153 ammation affects the clearance of 50nm lipid nanocapsules, or is exacerbated by their pulmonary admin

154 different biomaterial types, pegylated lipid nanocapsules, polyvinyl acetate (PVAc) and polystyrene n

155 These nanocapsules possess greatly enhanced stability, retaine

156 Despite the diversity of methods for nanocapsule preparation, methods for efficiently functio

157 tor dyes were entrapped in vesicle-templated nanocapsules prepared by copolymerization of tert-butyl

158 ied to more than 500% in curcumin-conjugated nanocapsules prepared from the above procedure.

159 the nanocapsules, being the sizes higher for nanocapsules produced with increasing concentrations of

160 The effect of coating constituents on nanocapsule properties were characterized.

161 antibody adsorbed onto the PSS shell of the nanocapsules provided the recognition molecule.

162 The nanocapsule provokes negligible cytokine release, enabli

163 The size of the dried nanocapsules ranged between 227 and 283 nm.

164 Treatment with nanocapsules resulted in a major reduction of nitric oxi

165 The porous nanocapsules retain molecules larger than the pore size

166 rB and PFN were loaded in a porous polymeric nanocapsule rich in acetylcholine analogues and matrix m

167 mplete seam of coordination bonds around the nanocapsule's typically octa-metalated belt.

168 LHRH-conjugated nanocapsules selectively delivered recombinant human tum

169 s, manipulation, and assembling of plasmonic nanocapsule SERS sensors for high-sensitivity biochemica

170 given quantity of antibody, the bioconjugate nanocapsules showed 30 times greater sensitivity and a s

171 The neutrally charged nGPM nanocapsules showed as long circulating time and accumul

172 These nanocapsules showed improved photolysis efficiency over

173 roximately 80% for both polyphenols, and the nanocapsules showed the highest synergistic antioxidant

174 On the other hand, blank nanocapsules showed very low cytotoxicity.

175 The silica-coated magnetic nanocapsules (SiMNCs) allow on-demand drug release via r

176 showed that the presence of AgNPs reduces Rf nanocapsules size (from 340 to 327 nm), increases the en

177 Nanocapsules' sizes ranged from 100 to 250 nm and were s

178 ithelium (RPE) in the mouse eye using silica nanocapsules (SNCs) as a treatment for retinal degenerat

179 vourable colloidal properties), silica-based nanocapsules (SNCs) with a size cutoff of approximately

180 tin were bioaccessible, the digesta retained nanocapsule structures and cytotoxicity, and the cytotox

181 on methylcellulose (MC) and alpha-tocopherol nanocapsule suspension (NCs) were developed.

182 re, we report the discovery of a enantiopure nanocapsule that is formed through the self-assembly of

183 chanically interlocking molecules to produce nanocapsules that are decorated on their exterior.

184 Vaults are self-assembled ribonucleoprotein nanocapsules that consist of multiple copies of three pr

185 chieved by encapsulating the proteins within nanocapsules that contain choline and acetylcholine anal

186 is achieved by encapsulating the mAbs within nanocapsules that contain choline and acetylcholine anal

187 into the system resulted in the formation of nanocapsules that were cleaved under specific conditions

188 imited space of preformed rod-shaped polymer nanocapsules, thereby avoiding the complex nucleation ki

189 Individual components enter hollow nanocapsules through nanopores in the capsule shell.

190 analogues facilitate the penetration of the nanocapsules through the brain-blood barrier and the del

191 degrees C) in a biocompatible, silica-based nanocapsule to achieve both stable dispersion and contro

192 in biomimetic extracellular matrix as a cell nanocapsule to carry nanoparticles (CN(2) ).

193 (70), which is encapsulated in two different nanocapsules to achieve the Bingel bis-cyclopropanation

194 es showed the capacity of shC/EBPbeta-loaded nanocapsules to downregulate C/EBPbeta levels in MDSCs a

195 res showed the capacity of miR 142-3p-loaded nanocapsules to reduce the highly immunosuppressive mono

196 ffraction structure of a dimeric zinc-seamed nanocapsule using a mixed pyrogallol/resorcinol[4]arene

197 enabled the successful directed assembly of nanocapsules using a reversible addition-fragmentation c

198 this information, we were able to design new nanocapsules using ternary mixtures of lipid and cholest

199 the facile synthesis of monodisperse polymer nanocapsules via a redox-mediated kinetic strategy from

200 interior of metal-organic pyrogallol[4]arene nanocapsules via aqueous "gates".

201 cavitands were shown to form supramolecular nanocapsules via assembly around a range of guest molecu

202 The average size of nanocapsule was in a range 150-400 nm.

203 oxygen sensors, encapsulation into oily core nanocapsules was performed.

204 Fe content of nanocapsules was reported.

205 tter understand the complex chemistry inside nanocapsules, we design a multiscale nanoreactor simulat

206 Starch/Rf, Starch/AgNPs/Rf and Starch/AgNPs nanocapsules were characterized by Fourier-transform inf

207 und 100% of encapsulation efficiency and the nanocapsules were considered physically stable during 11

208 silencing target of HIV therapy, CCR5-siRNA nanocapsules were delivered into 293T cells and successf

209 Bioconjugate nanocapsules were fabricated by using polystyrene sulfon

210 When the nanocapsules were functionalized with CXCL13-the ligand

211 morphology and molecular organization of the nanocapsules were studied on dried and hydrated state.

212 earance and whole body distribution of lipid nanocapsules were unaffected by the presence of acute lu

213 d one particular approach involves molecular nanocapsules, where ligands are designed that will enfor

214 nitroxide was incarcerated into an octa acid nanocapsule, which was confirmed by 1H NMR and EPR spect

215 These nanocapsules, which comprise an oily core and a shell co

216 e siRNA molecule within a degradable polymer nanocapsule with a diameter around 20 nm and positive su

217 We report a nanocapsule with an inner cavity height (14.1 angstrom)

218 , larger than both the dimeric and hexameric nanocapsules with both octahedral and square-planar meta

219 association of AgNPs/Rf and AgNPs/Rf/Starch nanocapsules with BSA under physiological conditions.

220 Polymeric nanocapsules with cross-linked shells and the latent azi

221 amines in the polymerization, we endowed the nanocapsules with efficient cell-transduction and suffic

222 In addition, functionalization of nanocapsules with multiple pyridine molecules at the cap

223 Dyes are entrapped in hollow nanocapsules with nanometer-thin walls of controlled por

224 ass ratios were investigated and compared to nanocapsules with one polyphenol and their unencapsulate

225 xicity, and the cytotoxicity was higher than nanocapsules with only one polyphenol and free polypheno

226 However, to design nanocapsules with pre-defined properties, thorough under

227 e for hydrophobic drug encapsulation via MPN nanocapsules with scaled-up capability.

228 ion with chloroauric acid, forming graphitic nanocapsules with significant surface-enhanced Raman sig

229 The methodology led to stable nanocapsules with spherical morphology, a mean diameter

230 These carbon nanocapsules with tailorable structures and properties e

231 nyl groups, we obtained nanosized core-shell nanocapsules with the enzyme as the core and a cross-lin

232 These nanocapsules with tunable permeability show prolonged re

233 bronchial epithelial cells internalized the nanocapsules, with observed pulmonary retention exceedin

234 velop a delivery carrier, multilayer polymer nanocapsules, with the capacity to co-encapsulate two ty

235 Additionally, compared to OVA nanocapsules without the C7A components and native OVA w